Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 314
- 试验地点
- 1
- 主要终点
- death rate；average hospital day；cost of hospitalization
研究概览
简要总结
The purpose of this study is to determine whether the clinical pathway for acute ischemic stroke(with combination of traditional Chinese medicine and western medicine) is able to improve the outcome of acute ischemic stroke and evaluate its effect on hospital day and cost, etc. Meanwhile, the study will discuss the safety and efficiency of this kind of Clinical Pathway
详细描述
Eligibility Ages Eligible for Study: 18 Years to 85 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria:
Those clinically diagnosed with acute ischemic stroke ； 18-85 years old； Over 6 hours and within 14 days from onset 4<=NIHSS <=22; Informed consent signed by patient or his/her family ；
Exclusion Criteria:
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Ischemic stroke diagnosed with both criteria of traditional Chinese medicine and western medicine；
- •18-85 years old；
- •Over 6 hours and within 14 days from onset
- •4<=NIHSS <=22;
- •Informed consent signed by patient or his/her family ；
排除标准
- •Hemorrhagic stroke;
- •Cerebral hernia;
- •Serious heart, liver, lung, kidney functional failure,malignancy;
- •Not cooperative with physician;
- •Psychological disorder;
- •Already taken part in other clinical drug trial within the past 3 months
研究组 & 干预措施
pathway
aspirin，Chinese herbs；acupuncture；rehabilitation；health education；
干预措施: aspirin，chinese herbs； (Drug)
结局指标
主要结局
death rate；average hospital day；cost of hospitalization
时间窗: 3 months；discharge day
次要结局
- Modified Rankin Scale (mRS) National Institute of Health Stroke Scale (NIHSS) Barthel Index degree of satisfaction(7 day；30 day；3 months)